Project Better Respiratory Equipment Using Advanced Technologies for Healthcare Employees (B.R.E.A.T.H.E.), 66198-66200 [E9-29709]
Download as PDF
66198
Federal Register / Vol. 74, No. 238 / Monday, December 14, 2009 / Notices
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2006–26367]
Motor Carrier Safety Advisory
Committee; Request for Nominations
AGENCY: Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Request for Nominations to the
Motor Carrier Safety Advisory
Committee (MCSAC).
SUMMARY: The FMCSA solicits
nominations for interested persons in
the safety enforcement, safety advocacy,
and motor carrier industry (including
labor unions) communities to serve on
the MCSAC. The MCSAC is authorized
by the Safe, Accountable, Flexible,
Efficient Transportation Equity Act: A
Legacy for Users, Public Law 109–59.
The committee was established by
charter on September 8, 2006; the
charter was renewed on September 8,
2008. The Committee is charged with
providing advice and recommendations
to the FMCSA Administrator on the
needs, objectives, plans, approaches,
content, and accomplishments of
Federal motor carrier safety programs
and Federal motor carrier safety
regulations. More information about the
MCSAC, including reports, meeting
minutes and membership, can be found
on the MCSAC Web site at https://
mcsac.fmcsa.dot.gov/.
DATES: Nominations for the MCSAC
must be received on or before January
13, 2010.
FOR FURTHER INFORMATION CONTACT: Mr.
Jack Kostelnik, Acting Chief, Strategic
Planning and Program Evaluation
Division, Office of Policy Plans and
Regulation, Federal Motor Carrier Safety
Administration, 1200 New Jersey
Avenue, SE., Washington, DC 20590–
0001, 202–366–5721,
Jack.Kostelnik@dot.gov.
SUPPLEMENTARY INFORMATION:
mstockstill on DSKH9S0YB1PROD with NOTICES
I. Background
Section 4144 of the Safe, Accountable,
Flexible, Efficient Transportation Equity
Act: A Legacy for Users (SAFETEA–LU)
(Pub. L. 109–59, August 10, 2005),
required the Secretary to establish the
MCSAC. The Committee provides
advice and recommendations to the
Administrator of FMCSA on the needs,
objectives, plans, approaches, content,
and accomplishments of motor carrier
safety programs and motor carrier safety
regulations. Under its charter (https://
mcsac/about.htm), the Committee may
be comprised of up to 20 members
VerDate Nov<24>2008
17:54 Dec 11, 2009
Jkt 220001
appointed by the Administrator for up
to two-year terms. They are selected
from among individuals who are not
employees of FMCSA and who are
specially qualified to serve on the
Committee based on their education,
training, or experience. The members
include representatives of the motor
carrier industry, safety advocates, and
safety enforcement officials.
Representatives of a single enumerated
interest group may not constitute a
majority of the Committee members.
The Administrator designates a
chairman of the Committee from among
the members. Committee members must
not be officers or employees of the
Federal Government and serve without
pay.
The White House has issued guidance
to executive agencies and departments
that Federally registered lobbyists not be
appointed to agency advisory boards
and commissions. Pursuant to this
guidance, FMCSA will not consider for
appointment to the MCSAC any
individual who is subject to the
registration and reporting requirements
of the Lobbying Disclosure Act. 2 U.S.C.
1605.
The Administrator may allow a
member, when attending meetings of
the Committee or a subcommittee,
reimbursement of expenses authorized
under Section 5703 of Title 5, United
States Code and the Federal Travel
Regulation, 41 CFR Part 301, relating to
per diem, travel and transportation.
The FMCSA anticipates calling
Committee meetings at least four times
each year. Meetings are open to the
general public, except as provided
under the Federal Advisory Committee
Act (FACA) (5 U.S.C. App. 2). Notice of
each meeting is published in the
Federal Register at least 15 calendar
days prior to the date of the meeting.
II. Request for Nominations
The FMCSA seeks nominations for
membership to the MCSAC from
representatives of the safety
enforcement, safety advocacy, industry
(including labor unions) sectors with
specialized experience, education, or
training in commercial motor vehicle
issues. As allowed under the charter,
the Agency is increasing the
membership. The Agency is required
under FACA to appoint members of
diverse views and interests to ensure the
committee is balanced with appropriate
consideration of background. All
Committee members must be able to
attend three to four meetings each year
in person, or by teleconference.
Interested persons should have a
commitment to transportation safety,
knowledge of transportation issues,
PO 00000
Frm 00115
Fmt 4703
Sfmt 4703
experience on panels that deal with
transportation safety and a record of
collaboration and professional
experience in commercial motor vehicle
safety issues. For nomination
information or a nomination
application, please contact Jack
Kostelnik at 202–366–5721, or by e-mail
at Jack.Kostelnik@dot.gov. Nominations
must be received on or January 13, 2010.
Issued on: December 8, 2009.
Anne S. Ferro,
Administrator.
[FR Doc. E9–29700 Filed 12–11–09; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF VETERANS
AFFAIRS
Project Better Respiratory Equipment
Using Advanced Technologies for
Healthcare Employees (B.R.E.A.T.H.E.)
Department of Veterans Affairs.
Notice.
AGENCY:
ACTION:
SUMMARY: The National Center for
Occupational Health and Infection
Control, [administered by the Office of
Public Health and Environmental
Hazards, Veterans Health
Administration (VHA), Department of
Veterans Affairs (VA)], is seeking to
partner with commercial organizations
that have respirator design and
manufacturing capabilities through a
Cooperative Research and Development
Agreement (CRADA), under the
authority of the Federal Technology
Transfer Act of 1986, Public Law 99–
502, 100 Stat. 1785 (codified as
amended in scattered sections of 15
U.S.C. (the FTTA). The CRADA is on a
research endeavor called Better
Respiratory Equipment using Advanced
Technologies for Healthcare Employees
(or Project B.R.E.A.T.H.E.) that aims to
develop a new respirator for health care
workers. The genesis and emphasis of
Project B.R.E.A.T.H.E. grew from
recommendations issued by the Institute
of Medicine in November 2007 in its
report Preparing for an Influenza
Pandemic: Personal Protective
Equipment for Healthcare Workers,
which articulates the next steps to be
taken toward better respiratory
protection for health care workers.
SUPPLEMENTARY INFORMATION: The
Project B.R.E.A.T.H.E. Working Group
constitutes an interagency effort of the
U.S. Federal Government, initiated and
chaired by VA and co-chaired by the
National Institute for Occupational
Safety and Health (NIOSH), in the
Centers for Disease Control and
Prevention, the Department of Health
E:\FR\FM\14DEN1.SGM
14DEN1
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 74, No. 238 / Monday, December 14, 2009 / Notices
and Human Services. This multidisciplinary team had a broad range of
expertise, including pandemic and
emergency preparedness, infectious
disease medicine and epidemiology,
respirator and personal protective
equipment policy and regulation,
occupational and environmental
medicine, respirator and materials
science, infection control, respirator
physiology, physics, and biosecurity.
The purpose of the Working Group is to
bring a new respirator to the U.S.
marketplace for health care workers
using a government-academic-private
partnership development model. During
the first phase of Project B.R.E.A.T.H.E.,
a working group representing nine
Federal agencies was convened and
produced 28 consensus
recommendations that, if implemented,
would be expected to improve the
function and utility of respiratory
protective equipment used by health
care workers employed by VHA and
beyond. The consensus
recommendations comprise desirable
characteristics of a respirator, and
respiratory protection programs, which
fall into one of four (4) actionable
categories:
• Respirators should perform their
intended functions effectively and
safely.
• Respirators should support, not
interfere with, occupational activities.
• Respirators should be comfortable
and tolerable.
• Respiratory protective programs
should comply with Federal standards
and guidelines, state regulations, and
local policies.
Under the CRADA, the duties of the
Federal Government will include the
following:
• the National Institute for
Occupational Safety and Health
(NIOSH) will evaluate, to the extent
possible, the respirator prototype(s), to
determine whether the respirator under
evaluation meets or exceeds the
performance requirements identified in
the consensus recommendations.
• VA’s Office of Public Health and
Environmental Hazards will seek the
collective expertise of some or all of the
Project B.R.E.A.T.H.E. Working Group
members regarding optimal product
development.
• VA’s National Center for
Occupational Health and Infection
Control will pursue, to the extent
possible, clinical testing of resulting
respirator prototype(s), including
feedback from health care workers.
VA is seeking to identify commercial
organizations with the respirator design
and manufacturing capabilities to
VerDate Nov<24>2008
17:54 Dec 11, 2009
Jkt 220001
construct a new respirator, based on the
aforementioned characteristics.
Collaboration will be made via a
CRADA under the authority of the
FTTA. 15 U.S.C. 3710a. Under the
FTTA, no Federal funds may be
provided to the collaborator, but the
Federal laboratory is authorized to grant
to the collaborating party a license or an
assignment to inventions made under
the CRADA.
Resource constraints may limit the
number of candidate organizations that
may be included and/or the extent of
government supplied testing in this
research program. VA will select one or
more declared partnering candidates
with respirator design and commercial
manufacturing capabilities using the
following criteria:
(1) The candidate organization has the
capability to develop a new respirator
prototype(s) utilizing advanced
technologies within 6 to 12 months;
(2) The candidate organization has the
resources, or access to the technological
resources, to construct the desired new
respirator prototype(s) through
commercial models.
(3) The candidate organization has the
capabilities to mass produce the
successful respirator model within 6
months of final pre-commercial model
approval; and
(4) The candidate organization has
prior experience with, and received
prior certification from, NIOSH for
respiratory protection products.
Candidate organizations will be
evaluated based on their capability to
incorporate the identified consensus
characteristics into the prototype(s) and
meet the established criteria. Candidates
selected most likely will be requested to
enter into a CRADA with VA and/or
other Federal agencies. In considering
candidates, special consideration will
be given to small business firms and
consortia involving small business
firms; and preference will be given to
businesses located in the United States
which agree that products embodying
inventions made under the CRADA will
be manufactured substantially in the
United States. 15 U.S.C. 3710a(c)(4).
This announcement does not obligate
VA to enter into a contractual agreement
with any respondents. VA reserves the
right to establish a partnership based on
scientific analysis and capabilities
found by way of this announcement or
other searches, if determined to be in
the best interest of the government.
Discomfort and intolerance were
frequent complaints of health care
workers in Toronto, Ontario, Canada
who wore respiratory protection during
the 2003 Severe Acute Respiratory
Syndrome crisis. During the outbreak,
PO 00000
Frm 00116
Fmt 4703
Sfmt 4703
66199
many Canadian public health
organizations advised health care
workers to use respiratory protection
throughout the course of their work
shifts, which often lasted 12 hours or
longer. Notwithstanding the ostensible
protection provided by respirators,
workers complained about headaches,
facial heat and pressure, shortness of
breath, interference with occupational
duties, among other problems associated
with their use. Respirator-associated
discomfort and occupational
interference were viewed as significant
limiting factors in work performance.
Concerns have been raised about the
same or similar events occurring in the
U.S. during future epidemics.
In 2006, the National Personal
Protective Technology Laboratory at
NIOSH made a request to the Institute
of Medicine for a review of personal
protective equipment, with the explicit
purpose of recommending how to best
protect health care workers during an
influenza pandemic. In its report,
Preparing for an Influenza Pandemic:
Personal Protective Equipment for
Healthcare Workers, the Institute of
Medicine noted a conspicuous lack of
evidence behind respirator protective
measures, including minimal attention
placed on the development of
equipment meeting the unique needs of
the health care workforce. The Institute
of Medicine recommended revisiting
elemental aspects of respirator design
and development, including distinct
attention to respirators tailored to the
jobs performed by health care workers,
and pursuing an evidence-based
approach to equipment design to the
extent that this is possible. Further, the
Report stressed the need for urgent
action, emphasizing that the next
influenza pandemic could occur in the
near future.
An extensive research network and
immense health care system make VHA
uniquely poised to marshal the
development of one or more new
respirators to the U.S. marketplace in
partnership with other Federal partners.
VA hospitals should provide for an
excellent test environment to assess and
guide prototype design, development
and revision. VA health care workers,
who stand to receive the most benefit
from a new respirator, are poised to
assist with development. The Nation’s
VA medical centers employ
approximately 118,000 health care
workers who wear and discard
approximately 1.6 million respirators
per year at its 900+ outpatient clinics,
150+ hospitals and some 136 nursing
homes. Provision of a safe workplace
where health care workers can carry-out
their occupational duties in a secure
E:\FR\FM\14DEN1.SGM
14DEN1
66200
Federal Register / Vol. 74, No. 238 / Monday, December 14, 2009 / Notices
environment without undue risk, during
both periods of routine operations and
times of crisis, is mission critical.
DATES: Submit letters of interest within
30 days after the date of publication of
this notice in the Federal Register.
mstockstill on DSKH9S0YB1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Interested commercial organizations
VerDate Nov<24>2008
17:54 Dec 11, 2009
Jkt 220001
with respirator design and
manufacturing capabilities should
submit a letter of interest with
information about their capabilities to:
Attention: Kimberly Rumping, The
National Center for Occupational Health
and Infection Control, Office of Public
Health and Environmental Hazards,
Veterans Health Administration, 1601
PO 00000
Frm 00117
Fmt 4703
Sfmt 4703
SW Archer Road (151B), Gainesville,
Florida 32608, E-mail:
Kimberly.Rumping@va.gov.
Approved: December 8, 2009.
John R. Gingrich,
Chief of Staff, Department of Veterans Affairs.
[FR Doc. E9–29709 Filed 12–11–09; 8:45 am]
BILLING CODE 8320–01–P
E:\FR\FM\14DEN1.SGM
14DEN1
Agencies
[Federal Register Volume 74, Number 238 (Monday, December 14, 2009)]
[Notices]
[Pages 66198-66200]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-29709]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Project Better Respiratory Equipment Using Advanced Technologies
for Healthcare Employees (B.R.E.A.T.H.E.)
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Center for Occupational Health and Infection
Control, [administered by the Office of Public Health and Environmental
Hazards, Veterans Health Administration (VHA), Department of Veterans
Affairs (VA)], is seeking to partner with commercial organizations that
have respirator design and manufacturing capabilities through a
Cooperative Research and Development Agreement (CRADA), under the
authority of the Federal Technology Transfer Act of 1986, Public Law
99-502, 100 Stat. 1785 (codified as amended in scattered sections of 15
U.S.C. (the FTTA). The CRADA is on a research endeavor called Better
Respiratory Equipment using Advanced Technologies for Healthcare
Employees (or Project B.R.E.A.T.H.E.) that aims to develop a new
respirator for health care workers. The genesis and emphasis of Project
B.R.E.A.T.H.E. grew from recommendations issued by the Institute of
Medicine in November 2007 in its report Preparing for an Influenza
Pandemic: Personal Protective Equipment for Healthcare Workers, which
articulates the next steps to be taken toward better respiratory
protection for health care workers.
SUPPLEMENTARY INFORMATION: The Project B.R.E.A.T.H.E. Working Group
constitutes an interagency effort of the U.S. Federal Government,
initiated and chaired by VA and co-chaired by the National Institute
for Occupational Safety and Health (NIOSH), in the Centers for Disease
Control and Prevention, the Department of Health
[[Page 66199]]
and Human Services. This multi-disciplinary team had a broad range of
expertise, including pandemic and emergency preparedness, infectious
disease medicine and epidemiology, respirator and personal protective
equipment policy and regulation, occupational and environmental
medicine, respirator and materials science, infection control,
respirator physiology, physics, and biosecurity. The purpose of the
Working Group is to bring a new respirator to the U.S. marketplace for
health care workers using a government-academic-private partnership
development model. During the first phase of Project B.R.E.A.T.H.E., a
working group representing nine Federal agencies was convened and
produced 28 consensus recommendations that, if implemented, would be
expected to improve the function and utility of respiratory protective
equipment used by health care workers employed by VHA and beyond. The
consensus recommendations comprise desirable characteristics of a
respirator, and respiratory protection programs, which fall into one of
four (4) actionable categories:
Respirators should perform their intended functions
effectively and safely.
Respirators should support, not interfere with,
occupational activities.
Respirators should be comfortable and tolerable.
Respiratory protective programs should comply with Federal
standards and guidelines, state regulations, and local policies.
Under the CRADA, the duties of the Federal Government will include
the following:
the National Institute for Occupational Safety and Health
(NIOSH) will evaluate, to the extent possible, the respirator
prototype(s), to determine whether the respirator under evaluation
meets or exceeds the performance requirements identified in the
consensus recommendations.
VA's Office of Public Health and Environmental Hazards
will seek the collective expertise of some or all of the Project
B.R.E.A.T.H.E. Working Group members regarding optimal product
development.
VA's National Center for Occupational Health and Infection
Control will pursue, to the extent possible, clinical testing of
resulting respirator prototype(s), including feedback from health care
workers.
VA is seeking to identify commercial organizations with the
respirator design and manufacturing capabilities to construct a new
respirator, based on the aforementioned characteristics. Collaboration
will be made via a CRADA under the authority of the FTTA. 15 U.S.C.
3710a. Under the FTTA, no Federal funds may be provided to the
collaborator, but the Federal laboratory is authorized to grant to the
collaborating party a license or an assignment to inventions made under
the CRADA.
Resource constraints may limit the number of candidate
organizations that may be included and/or the extent of government
supplied testing in this research program. VA will select one or more
declared partnering candidates with respirator design and commercial
manufacturing capabilities using the following criteria:
(1) The candidate organization has the capability to develop a new
respirator prototype(s) utilizing advanced technologies within 6 to 12
months;
(2) The candidate organization has the resources, or access to the
technological resources, to construct the desired new respirator
prototype(s) through commercial models.
(3) The candidate organization has the capabilities to mass produce
the successful respirator model within 6 months of final pre-commercial
model approval; and
(4) The candidate organization has prior experience with, and
received prior certification from, NIOSH for respiratory protection
products.
Candidate organizations will be evaluated based on their capability
to incorporate the identified consensus characteristics into the
prototype(s) and meet the established criteria. Candidates selected
most likely will be requested to enter into a CRADA with VA and/or
other Federal agencies. In considering candidates, special
consideration will be given to small business firms and consortia
involving small business firms; and preference will be given to
businesses located in the United States which agree that products
embodying inventions made under the CRADA will be manufactured
substantially in the United States. 15 U.S.C. 3710a(c)(4). This
announcement does not obligate VA to enter into a contractual agreement
with any respondents. VA reserves the right to establish a partnership
based on scientific analysis and capabilities found by way of this
announcement or other searches, if determined to be in the best
interest of the government.
Discomfort and intolerance were frequent complaints of health care
workers in Toronto, Ontario, Canada who wore respiratory protection
during the 2003 Severe Acute Respiratory Syndrome crisis. During the
outbreak, many Canadian public health organizations advised health care
workers to use respiratory protection throughout the course of their
work shifts, which often lasted 12 hours or longer. Notwithstanding the
ostensible protection provided by respirators, workers complained about
headaches, facial heat and pressure, shortness of breath, interference
with occupational duties, among other problems associated with their
use. Respirator-associated discomfort and occupational interference
were viewed as significant limiting factors in work performance.
Concerns have been raised about the same or similar events occurring in
the U.S. during future epidemics.
In 2006, the National Personal Protective Technology Laboratory at
NIOSH made a request to the Institute of Medicine for a review of
personal protective equipment, with the explicit purpose of
recommending how to best protect health care workers during an
influenza pandemic. In its report, Preparing for an Influenza Pandemic:
Personal Protective Equipment for Healthcare Workers, the Institute of
Medicine noted a conspicuous lack of evidence behind respirator
protective measures, including minimal attention placed on the
development of equipment meeting the unique needs of the health care
workforce. The Institute of Medicine recommended revisiting elemental
aspects of respirator design and development, including distinct
attention to respirators tailored to the jobs performed by health care
workers, and pursuing an evidence-based approach to equipment design to
the extent that this is possible. Further, the Report stressed the need
for urgent action, emphasizing that the next influenza pandemic could
occur in the near future.
An extensive research network and immense health care system make
VHA uniquely poised to marshal the development of one or more new
respirators to the U.S. marketplace in partnership with other Federal
partners. VA hospitals should provide for an excellent test environment
to assess and guide prototype design, development and revision. VA
health care workers, who stand to receive the most benefit from a new
respirator, are poised to assist with development. The Nation's VA
medical centers employ approximately 118,000 health care workers who
wear and discard approximately 1.6 million respirators per year at its
900+ outpatient clinics, 150+ hospitals and some 136 nursing homes.
Provision of a safe workplace where health care workers can carry-out
their occupational duties in a secure
[[Page 66200]]
environment without undue risk, during both periods of routine
operations and times of crisis, is mission critical.
DATES: Submit letters of interest within 30 days after the date of
publication of this notice in the Federal Register.
FOR FURTHER INFORMATION CONTACT: Interested commercial organizations
with respirator design and manufacturing capabilities should submit a
letter of interest with information about their capabilities to:
Attention: Kimberly Rumping, The National Center for Occupational
Health and Infection Control, Office of Public Health and Environmental
Hazards, Veterans Health Administration, 1601 SW Archer Road (151B),
Gainesville, Florida 32608, E-mail: Kimberly.Rumping@va.gov.
Approved: December 8, 2009.
John R. Gingrich,
Chief of Staff, Department of Veterans Affairs.
[FR Doc. E9-29709 Filed 12-11-09; 8:45 am]
BILLING CODE 8320-01-P